Literature DB >> 2123464

Efficient transformation of chicken embryo fibroblasts by c-Jun requires structural modification in coding and noncoding sequences.

T J Bos1, F S Monteclaro, F Mitsunobu, A R Ball, C H Chang, T Nishimura, P K Vogt.   

Abstract

To assess the transforming capability of the c-Jun protein, we introduced the chicken c-jun proto-oncogene into a replication competent avian retroviral expression vector (RCAS). Viral Jun efficiently transformed chicken embryo fibroblasts (CEFs) when expressed from this vector. Overexpression of c-Jun leads to transformation of CEFs with an efficiency that is 15- to 25-fold less than that seen for v-Jun, suggesting that v-Jun contains structural features that increase its oncogenic potential relative to c-Jun. There are four structural differences between v-Jun and c-Jun. To determine the relative contribution that each of these structural differences between v-Jun and c-Jun has on oncogenic activity, several deletion and substitution mutants were constructed. Each of these mutants was expressed in CEF and assayed for transformation by focus formation. Analysis of the results reveals that deletion of a region of 27 amino acids near the amino terminus of c-Jun and deletion of 3'-untranslated sequences are critical in activating the full oncogenic potential of Jun.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2123464     DOI: 10.1101/gad.4.10.1677

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  63 in total

1.  Complex functions of AP-1 transcription factors in differentiation and survival of PC12 cells.

Authors:  S Leppä; M Eriksson; R Saffrich; W Ansorge; D Bohmann
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

2.  Induction of apoptosis by the transcription factor c-Jun.

Authors:  E Bossy-Wetzel; L Bakiri; M Yaniv
Journal:  EMBO J       Date:  1997-04-01       Impact factor: 11.598

Review 3.  Nuclear protein phosphorylation and growth control.

Authors:  D W Meek; A J Street
Journal:  Biochem J       Date:  1992-10-01       Impact factor: 3.857

4.  Addition of N-terminal peptide sequences activates the oncogenic and signaling potentials of the catalytic subunit p110α of phosphoinositide-3-kinase.

Authors:  Minghao Sun; Jonathan R Hart; Petra Hillmann; Marco Gymnopoulos; Peter K Vogt
Journal:  Cell Cycle       Date:  2011-11-01       Impact factor: 4.534

5.  Heparin-binding epidermal growth factor-like growth factor, a v-Jun target gene, induces oncogenic transformation.

Authors:  S l Fu; I Bottoli; M Goller; P K Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

6.  Nuclear translocation of viral Jun but not of cellular Jun is cell cycle dependent.

Authors:  K Chida; P K Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

7.  Rare cancer-specific mutations in PIK3CA show gain of function.

Authors:  Marco Gymnopoulos; Marc-André Elsliger; Peter K Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-21       Impact factor: 11.205

8.  Oncogenic transformation induced by the p110beta, -gamma, and -delta isoforms of class I phosphoinositide 3-kinase.

Authors:  Sohye Kang; Adam Denley; Bart Vanhaesebroeck; Peter K Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

9.  Synthetic molecules for disruption of the MYC protein-protein interface.

Authors:  Nicholas T Jacob; Pedro O Miranda; Ryan J Shirey; Ritika Gautam; Bin Zhou; M Elena de Orbe Izquierdo; Mark S Hixon; Jonathan R Hart; Lynn Ueno; Peter K Vogt; Kim D Janda
Journal:  Bioorg Med Chem       Date:  2018-07-11       Impact factor: 3.641

10.  Akt-mediated regulation of NFkappaB and the essentialness of NFkappaB for the oncogenicity of PI3K and Akt.

Authors:  Dong Bai; Lynn Ueno; Peter K Vogt
Journal:  Int J Cancer       Date:  2009-12-15       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.